Alzheimer's Disease Trial, Recruiting (NCT07435467)

Alzheimer's Disease Trial, Recruiting NCT07435467 Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07435467 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1: You are currently in hospital and have been diagnosed with one of the following: ischemic stroke (blocked blood vessel in the brain), hemorrhagic stroke (bleeding in the brain), delirium (sudden severe confusion), status epilepticus (prolonged or repeated seizures), or encephalitis/meningitis (inflammation or infection of the brain or its surrounding membranes)
Group 2: You are currently in hospital for a condition that is not neurological (not brain or nerve related), and you have been diagnosed with a significant form of dementia according to recognised medical criteria
Group 3: You are currently in hospital for a condition that is not neurological (not brain or nerve related), and you do not have a diagnosis of dementia

Who may not be able to join:

You are unable or unwilling to give your informed consent to take part in the trial
For Groups 2 and 3: You have been diagnosed with ischemic stroke, hemorrhagic stroke, delirium, status epilepticus, or encephalitis/meningitis (these patients would be considered for Group 1 instead)
For Group 3: You have a diagnosis of dementia (these patients would be considered for Group 2 instead)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fabiola Olivieri, Professor, IRCCS INRCA, Ancona, Italy

Phone: +390718003719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07435467

Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +390718003719

More information: https://clinicaltrials.gov/study/NCT07435467

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Group 1: You are currently in hospital and have been diagnosed with one of the following: ischemic stroke (blocked blood vessel in the brain), hemorrhagic stroke (bleeding in the brain), delirium (sudden severe confusion), status epilepticus (prolonged or repeated seizures), or encephalitis/meningitis (inflammation or infection of the brain or its surrounding membranes)
Group 2: You are currently in hospital for a condition that is not neurological (not brain or nerve related), and you have been diagnosed with a significant form of dementia according to recognised medical criteria
Group 3: You are currently in hospital for a condition that is not neurological (not brain or nerve related), and you do not have a diagnosis of dementia

Who may not be able to join:

You are unable or unwilling to give your informed consent to take part in the trial
For Groups 2 and 3: You have been diagnosed with ischemic stroke, hemorrhagic stroke, delirium, status epilepticus, or encephalitis/meningitis (these patients would be considered for Group 1 instead)
For Group 3: You have a diagnosis of dementia (these patients would be considered for Group 2 instead)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituto Nazionale di Ricovero e Cura per Anziani

Registry

ClinicalTrials.gov

Start date

9 April 2025

Est. completion

30 June 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

All-cause Mortality; Number of hospital readmission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov